SHELTON, Conn. (News release) -- Edgewell Personal Care Company announced that it has completed the sale of its feminine care business to Essity, a leading global health and hygiene company based in Sweden, for $340 million. Edgewell intends to use the net proceeds from the sale, after taxes and transaction costs, primarily to strengthen its balance sheet and pay down the balance of U.S. revolving credit facility while continuing to invest in the long-term growth of its core businesses.

"Completing the sale of our Feminine Care business is a pivotal step in Edgewell's transformation. By simplifying our portfolio and focusing our resources on shave, sun and skin care, and grooming, we are positioning Edgewell to be a more focused, agile and durable personal care company," said Edgewell President and CEO Rod Little. "The proceeds from this transaction will strengthen our balance sheet, support debt reduction and reinvestment behind our core brands and innovation pipeline, as we look to drive sustainable growth and long‑term value for shareholders, while our Feminine Care colleagues gain new opportunities as part of Essity, a global leader in health and hygiene."

Edgewell expects to work closely with Essity to ensure a smooth transition for employees, customers, and consumers of the Feminine Care business. The Company and Essity entered into a Transition Services Agreement to provide certain support services in the areas of accounting, information technology, quality assurance, operations and supply chain, and sales for a period of at least one year from the closing of the transaction.

The Company will provide unaudited condensed consolidated financial information prepared in accordance with Article 11 of Regulation S-X to reflect the sale of the Feminine Care business as a discontinued operation. This pro forma condensed consolidated financial information is expected to be made available to investors in a Current Report on Form 8-K on or before February 6, 2026, while additional supplemental financial information will be provided during the Company's First Quarter Fiscal 2026 earnings call on February 9, 2026.

****

Essity press release

STOCKHOLM -- Hygiene and health company Essity has completed the acquisition of Edgewell Personal Care's feminine care business, including the Carefree, Stayfree and o.b. brands in North America and global feminine care rights for the Playtex brand. The purchase price for the assets amounts to USD 340m (approximately SEK 3bn) on a cash and debt-free basis. The acquisition supports Essity's strategy to focus on high margin categories and to grow market positions in the US, the world's largest hygiene market.

The completed asset deal includes a broad product portfolio of liners, pads and tampons under well-known brands in the US, Canada, and the Caribbean as well as a production facility in Dover, Delaware. The operations will be consolidated into Essity's accounts as of February 2, 2026.

"As we finalize this acquisition, we look forward to accelerating the growth of these well-known brands using our established recipe for success within Feminine Care. This strengthens Essity's personal care business in North America and supports our ambition to grow in high yielding categories and key geographies," says Ulrika Kolsrud, President and CEO of Essity.

Essity is a fast-growing player in the feminine care category, with several strong regional brands such as Libresse, Bodyform, Nana, Saba, Libra, Nosotras, Knix and Modibodi offering a broad product portfolio of pads, liners, tampons, intimate soaps, intimate wipes, leakproof apparel and menstrual cups.